CARLSBAD, Calif., July 03, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) AFIB, an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on July 1, 2023 that were approved by the Compensation Committee of its Board of Directors…Read More
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635c4 Acutus Medical NASDAQAFIB
